Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease

被引:6
|
作者
Zahratka, Jeffrey A. [1 ]
Shao, Yvonne [1 ]
Shaw, McKenzie [1 ]
Todd, Kaitlin [1 ]
Formica, Shane V. [1 ]
Khrestian, Maria [1 ]
Montine, Thomas [2 ]
Leverenz, James B. [3 ]
Bekris, Lynn M. [1 ]
机构
[1] Cleveland Clin Fdn, Genom Med Inst, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA
[3] Cleveland Clin, Neurol Inst, Lou Ruvo Ctr Brain Hlth, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Fyn; Alzheimer's disease; SNP; Cerebellum; Hippocampus; Reporter assay; TYROSINE PROTEIN-KINASE; CELLULAR PRION PROTEIN; GLUTAMATE-RECEPTOR; 5; COGNITIVE IMPAIRMENTS; TAU PHOSPHORYLATION; AMYLOID-BETA; A-BETA; TAUOPATHIES; ISOFORM; NEURONS;
D O I
10.1016/j.neurobiolaging.2016.11.001
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Neurofibrillary tangles (NFTs), composed of hyperphosphorylated tau, are a key pathologic feature of Alzheimer's disease (AD). Tau phosphorylation is under the control of multiple kinases and phosphatases, including Fyn. Previously, our group found an association between 2 regulatory single nucleotide polymorphisms in the FYN gene with increased tau levels in the cerebrospinal fluid. In this study, we hypothesized that Fyn expression in the brain is influenced by AD status and genetic content. We found that Fyn protein, but not messenger RNA, levels were increased in AD patients compared to cognitively normal controls and are associated with regulatory region single nucleotide polymorphisms. In addition, the expression of the FYN 3'UTR can decrease expression in multiple cell lines, suggesting this regulatory region plays an important role in FYN expression. Taken together, these data suggest that FYN expression is regulated according to AD status and regulatory region haplotype, and genetic variants may be instrumental in the development of neurofibrillary tangles in AD and other tauopathies. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:43 / 53
页数:11
相关论文
共 50 条
  • [1] FYN expression is associated with regulatory region genetic variation
    Bekris, L. M.
    Zahratka, J. A.
    Shao, Y.
    Shaw, M.
    Todd, K.
    Khrestian, M.
    Leverenz, J. B.
    MOVEMENT DISORDERS, 2016, 31 : S441 - S441
  • [2] Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression
    Theuns, J
    Del-Favero, J
    Dermaut, B
    van Duijn, CM
    Backhovens, H
    Van den Broeck, M
    Serneels, S
    Corsmit, E
    Van Broeckhoven, C
    Cruts, M
    HUMAN MOLECULAR GENETICS, 2000, 9 (03) : 325 - 331
  • [3] Genetic and regulatory architecture of Alzheimer's disease in the APOE region
    Kulminski, Alexander M.
    Shu, Leonardo
    Loika, Yury
    He, Liang
    Nazarian, Alireza
    Arbeev, Konstantin
    Ukraintseva, Svetlana
    Yashin, Anatoliy
    Culminskaya, Irina
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [4] Genetic variation in APOE cluster region and Alzheimer's disease risk
    Cervantes, Sebastian
    Samaranch, Lluis
    Manuel Vidal-Taboada, Jose
    Lamet, Isabel
    Jesus Bullido, Maria
    Frank-Garcia, Ana
    Coria, Francisco
    Lleo, Albert
    Clarimon, Jordi
    Lorenzo, Elena
    Alonso, Elena
    Sanchez-Juan, Pascual
    Rodriguez-Rodriguez, Eloy
    Combarros, Onofre
    Rosichi, Marcel
    Vilella, Elisabet
    Pastor, Pau
    NEUROBIOLOGY OF AGING, 2011, 32 (11) : 2107.e7 - 2107.e17
  • [5] The regulatory region polymorphisms of the MTHFR gene are not associated with Alzheimer's disease
    Wakutani, Y
    Kowa, H
    Kusumi, M
    Nakaso, K
    Isoe-Wada, K
    Yano, H
    Urakami, K
    Takeshima, T
    Nakashima, K
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (03) : 147 - 150
  • [6] Caspase-1 genetic variation is not associated with Alzheimer's disease risk
    Luis Vazquez-Higuera, Jose
    Rodriguez-Rodriguez, Eloy
    Sanchez-Juan, Pascual
    Mateo, Ignacio
    Pozueta, Ana
    Martinez-Garcia, Ana
    Frank, Ana
    Valdivieso, Fernando
    Berciano, Jose
    Bullido, Maria J.
    Combarros, Onofre
    BMC MEDICAL GENETICS, 2010, 11
  • [7] Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer's Disease Risk
    Bruce, Kimberley D.
    Tang, Maoping
    Reigan, Philip
    Eckel, Robert H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 15
  • [8] Targeting Fyn Kinase in Alzheimer's Disease
    Nygaard, Haakon B.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (04) : 369 - 376
  • [9] Fyn, a Potential Target for Alzheimer's Disease
    Yang, Kai
    Belrose, Jillian
    Trepanier, Catherine H.
    Lei, Gang
    Jackson, Michael F.
    MacDonald, John F.
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 27 (02) : 243 - 252
  • [10] Serum levels and genetic variation of TGF-β1 are not associated with Alzheimer's disease
    Rodriguez-Rodriguez, E.
    Sanchez-Juan, P.
    Mateo, I.
    Llorca, J.
    Infante, J.
    Garcia-Gorostiaga, I.
    Berciano, J.
    Combarros, O.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (06): : 409 - 412